Αρχική World News EMA recommends granting a marketing authorisation for daraxonrasib World News EMA recommends granting a marketing authorisation for daraxonrasib Από Ogkologos - 12 Νοεμβρίου, 2026 4 0 Facebook Twitter Google+ Pinterest WhatsApp Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR 2021/22 in review: Charity looks to the future with ambitious new... 21 Ιουλίου, 2022 Community Comes Together To Give Terminally Ill Father One Last Christmas... 18 Οκτωβρίου, 2021 ESMO Launches Living Guidelines to Enhance the Usability of its Clinical... 10 Μαΐου, 2023 How I’m Working to Erase the Stigma of Lung Cancer: A... 22 Νοεμβρίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Philanthropist Simon Collins: “I realised I could make a difference by... Mom Gives Birth and Receives a Breast Cancer Diagnosis on the... Undetectable MRD and Extended PFS More Common with MRD-guided Ibrutinib-Venetoclax than... When Prenatal DNA Tests Point to Cancer
